88IV - PR Newswire Asia's news - Health Care/Hospital


GSK Advocates Importance of Adult Immunisation amongst Malaysians KUALA LUMPUR, Malaysia, April 25, 2024 /PRNewswire/ -- As Malaysia's population shifts towards an ageing demographic, the importance of adult immunisation becomes increasingly apparent. By ... 2024-04-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono PRISM BioLab will utilize PepMetics ® , innovative small molecules that mimic three-dimensional structures of alpha-helix and beta-turns of peptides for drug discovery against oncology target ... 2024-04-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
United Imaging Healthcare Strengthens Partnership with MedikaBazaar for Indian Market Leadership COLOMBO, Sri Lanka , April 25, 2024 /PRNewswire/ -- United Imaging, a global leader in healthcare innovations, recently hosted a meeting with MedikaBazaar in Colombo, Sri Lanka , to strategically ... 2024-04-25T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting SAN FRANCISCO and SUZHOU, China , April 25, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures ... 2024-04-25T Health Care/Hospital Medical/Pharmaceuticals
ASCO 2024 \| Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST SUZHOU, China and ROCKVILLE, Md. , April 25, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis ... 2024-04-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Breakthrough in Lung Cancer Treatment: Dizal to Unveil Groundbreaking Results of Sunvozertinib for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations at 2024 ASCO Annual Meeting Topline results from Dizal's global pivotal phase II WU-KONG1 Part B study of sunvozertinib will be showcased in a featured oral presentation at the conference. ... 2024-04-24T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Future Health highlights greater access to treatment for Mental Health Month SAN FRANCISCO , April 24, 2024 /PRNewswire/ -- A recent poll has highlighted an alarming trend: a staggering 90% of Americans feel we are in a mental health crisis. While Mental Health Month ... 2024-04-24T Health Care/Hospital Medical/Pharmaceuticals
Meihua International Medical Technologies Co., Ltd. Reports 2023 Financial Year Results YANGZHOU, China , April 24, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider ... 2024-04-24T Banking/Financial Service Biotechnology Health Care/Hospital Medical Equipment
Esaote Group: Shareholders' Meeting approves financial statements as of 31 December 2023 Consolidated revenues up to 273.2 million (+6.5%), EBITDA stands at 41.7 million (+24.5%); EBIT up to 13.4 million and net profit up to 6.2 million. Sales increased in all business lines, ... 2024-04-24T Banking/Financial Service Computer Software Computer/Electronics Health Care/Hospital
CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy First non-immunosuppressive therapy for the treatment of IgA Nephropathy (IgAN) approved in Europe ... 2024-04-24T Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Health Care/Hospital